Beth Sandy, MSN, CRNP, FAPO, led a discussion on EGFR-mutated non-small cell lung cancer, focusing on targeted therapies for those with advanced, treatment-naïve disease.
Targeted Therapies for Locally Advanced or Metastatic EGFR-mutated NSCLC
Advertisement
Advertisement
